MECHANISMS OF RESISTANCE TO THE B-RAF INHIBITOR ZELBORAF IN FOUR MELANOMA CELL LINES

被引：0
|
作者：
Garg, E. [1 ]
Kong, X. [1 ]
Shi, H. [1 ]
Moriceau, G. [1 ]
Lo, R. S. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2012年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [1] The genesis of Zelboraf: Targeting mutant B-Raf in melanoma
    Davis, Matthew J.
    Schlessinger, Joseph
    JOURNAL OF CELL BIOLOGY, 2012, 199 (01): : 15 - 19
  • [2] Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UAI-201
    Lee, Michael
    Ahn, Jun-Ho
    Ahn, Soon Kil
    FASEB JOURNAL, 2012, 26
  • [3] Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152
    Kim, Yun-Ki
    Ahn, Soon Kil
    Lee, Michael
    CANCER LETTERS, 2012, 320 (02) : 215 - 224
  • [4] B-Raf inhibition in conjunctival melanoma cell lines with PLX 4720
    Riechardt, Aline I.
    Maier, Anna-Karina B.
    Nonnenmacher, Anika
    Reichhart, Nadine
    Keilholz, Ulrich
    Kociok, Norbert
    Strauss, Olaf
    Joussen, Antonia M.
    Gundlach, Enken
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (12) : 1739 - 1745
  • [5] Efficacy of a novel small molecule MER receptor tyrosine kinase inhibitor in B-RAF wild-type and B-RAF mutant melanoma cell lines
    Teodorovic, Lenka S.
    Carrico, Jacqueline
    DeRyckere, Deborah
    Zhang, Weihe
    Wang, Xiaodong
    Frye, Stephen
    Eckhardt, S. Gail
    Earp, H. Shelton
    Graham, Douglas K.
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Inactivation of Receptor Tyrosine Kinases Overcomes Resistance to Targeted B-RAF Inhibitors in Melanoma Cell Lines
    O. O. Ryabaya
    A. A. Malysheva
    Yu. A. Khochenkova
    E. Sh. Solomko
    D. A. Khochenkov
    Molecular Biology, 2018, 52 : 398 - 405
  • [7] Inactivation of Receptor Tyrosine Kinases Overcomes Resistance to Targeted B-RAF Inhibitors in Melanoma Cell Lines
    Ryabaya, O. O.
    Malysheva, A. A.
    Khochenkova, Yu. A.
    Solomko, E. Sh.
    Khochenkov, D. A.
    MOLECULAR BIOLOGY, 2018, 52 (03) : 398 - 405
  • [8] ANTITUMOR ACTIVITY OF B-RAF INHIBITOR (PLX4032) AGAINST A PANEL OF HUMAN MELANOMA CELL LINES
    Montecillo, M. L.
    Sondergaard, J.
    Ribas, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 210 - 210
  • [9] A Fluoro Derivative of Embelin, as Potent B-RAF Inhibitor in Melanoma
    Babu, Arunkumar
    Laila, Shiny P.
    Fernandez, Annette
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (15) : 2066 - 2074
  • [10] The role of B-RAF in melanoma
    Vanessa C. Gray-Schopfer
    Silvy da Rocha Dias
    Richard Marais
    Cancer and Metastasis Reviews, 2005, 24 : 165 - 183
12345